同和药业跌2.04%，成交额8251.47万元，主力资金净流入55.48万元

Group 1 - The core viewpoint of the articles highlights the recent performance and financial metrics of Tonghe Pharmaceutical, including stock price movements and trading volumes [1][2] - As of September 9, Tonghe Pharmaceutical's stock price was 9.11 yuan per share, with a market capitalization of 3.826 billion yuan [1] - The company has seen a year-to-date stock price increase of 14.88%, with a slight decline of 0.98% over the last five trading days [1] Group 2 - For the first half of 2025, Tonghe Pharmaceutical reported a revenue of 427 million yuan, reflecting a year-on-year growth of 11.88% [2] - The net profit attributable to shareholders for the same period was approximately 58.49 million yuan, showing a decrease of 15.91% compared to the previous year [2] - The company has distributed a total of 96.55 million yuan in dividends since its A-share listing, with 49.42 million yuan distributed over the last three years [2]